Abstract Pharmacological and biochemical properties were investigated on de anmino-dicarba-[Gly']-oxytocin (Y-5350). This is a newly developed compound, in which the disulfide bond and [Pro'] of deamino-oxytocin are substituted by an ethyl ene linkage and glycine respectively. Bioassayed Y-5350 exhibited 202.6 u/mg of oxytocic activity, 4.6 u/mg of avian depressor activity, 441.2 u/mg of rat milk-eject ing activity and 0.02 u/mg of rat antidiuretic activity, however, a depressor activity was also evident in rats. In particular, the duration of antidiuretic activity was short. Moreover, the oxytocic activity in pregnant rats and rabbits was weak in comparison with oxytocin. Cumulative dose-response studies were carried out on the isolated rat uterus using van Dyke-Hasting solution.
The role of disulfide linkage in neurohypophysial hormones has been widely investi gated (1) (2) (3) (4) (5) (6) (7) . After investigating the biological activities of crystalline deamino-dicarba oxytocin (Y-4266), in which the disulfide linkage of deamino-oxytocin was substituted by an ethylene linkage, Yamanaka et al. (8) concluded that the disulfide linkage was not essential for the biological activity of neurohypophysial hormones as reported on an amor phous product of Y-4266 (9-10). Thus, many deamino-dicarba-analogues of neurohypo physial hormones were synthesized and biological activities were investigated. Out of these analogues, deamino-dicarba-[Gly']-oxytocin (Y-5350) proved to be of great interest, and the pharmacological and biochemical properties were studied in detail.
MATERIALS AND METHODS

Deaniino-dicarba-[Gly']-oxytocin (Y-5350) and deamino-dicarbit-oxytocin (Y-4266)
have these chemical structures.
These compounds were synthesized in our laboratory. The following were used, oxytocin (Sankyo, SyntocinonL), posterior pituitary reference standard (The Pharmacopoeia of Japan 8th edition), diethylstilbestrol, urethane, heparin, phenobarbitone sodium and phen oxybenzamine.
The following apparatuses were used, the electric manometer (Nihon Kohden, MP 4T), the carrier amplifier (Nihon Kohden, RP-3), the recorder (Hitachi, QPD-73 or Rika denki, B-24), the force displacement transducer (Nihon Kohden, SB-IT), the conductivity meter (M&S Instrument Trading Inc.).
Isolated uterus of rat
Virgin Wistar rats weighing 150-200 g were used. Oestrus was induced by diethyl stilbestrol (1 mg/kg, s.c.), 24 hr and 48 hr prior to the start of experiments. The animal was stunned by a blow on the head and uterine horn was excised and isolated. Uterine contractions were recorded isotonically on a smoked drum. The weight of load on the uterus was 0.5 g.
(1) Assay of oxytocic activity: The isolated uterus was suspended in de Jalon solu tion (31-32'C), which was continuously oxygenated. The results were assessed statistical ly by the four-point assay procedure.
(2) Influence q.1' magnesium ion on uterine contractile activity: The isolated uterus was suspended in modified van Dyke-Hasting solution, with (2 mM or 0.5 mM) or without the magnesium ion. A mixture of oxygen and carbon dioxide (95: 5) was bubbled through the bathing solution. The method of cumulative dose-response curve (II) was employed for the analysis of affinity, intrinsic activity and influence of magnesium ion.
Isolated strip of rat mammary gland
The procedure used was generally the same as that of Ryden and Sjoholm (12) .
Healthy lactating Wistar rats weighing about 300 g were selected on the 3-15 day after parturition. The rats were sacrificed by a blow on the head and the lower mammary glands were isolated. A strip was suspended in Tyrode solution at 38'C. A mixture of oxygen and carbon dioxide (95: 5) was passed through the solution and an initial load of 160 mg was applied. The suspended strips were attached to a force displacement transducer.
With this transducer and a carrier amplifier, isometric contractions were measured and recorded. The results were assessed statistically by a four-point assay procedure.
;%lomnnrary gland in vii,e7
Milk-ejection activity was tested according to the modified method of Bisset et al. (13) .
Healthy lactating Wistar rats weighing about 300 g were used on the 3-15 day after par turition. The rats were anesthetized With urethane (1.5 g/kg, s.c.) within 30-60 min after the separation from their litters. The nipple tip of an abdominal mammary gland was in cised and the duct was cannulated with a polyethylene tube connected to an electric mano meter, which had been filled with rat serum. By an electric manometer and a carrier am plifier, changes of intra-mammary pressure were measured and recorded. The left femo ral vein was cannulated with polyethylene tube for intravenous injection. The results were assessed statistically by a four-point assay procedure.
Blood pressure of chicken The avian depressor activities were investigated by the modified method of Sturmer (14) . Healthy white Leghorn roosters weighing 1.8-2.3 kg were used. The birds were anesthetized with phenobarbitone sodium (200 mg/kg, i.rn.) and the ischiatic artery was cannulated. This cannula was connected with an electric manometer and a carrier am plifier. Changes of arterial blood pressure were recorded. Test solutions were injected in the left wing vein. The results were assessed statistically by a four-point assay proce
dure.
Blood pressure of rat The assay method established by Dekanski (15) was modified. Male Wistar rats weighing about 300 g were used. At 18 hr prior to the assay the rats were pretreated with phenoxybenzamine (10 mg/kg, s.c.). On the day of assay the rats were anesthetized with urethane (1.75 g/kg, s.c.). The trachea was cannulated to ensure a free airway. The right carotid artery was exposed and cannulated with polyethylene tube, which was con nected to an electric manometer. With an electric manometer and a carrier amplifier, changes of mean arterial blood pressure were measured and recorded. Test solutions were injected in the left femoral vein.
Conductirit .v of rat antic (Antidirrretic activity)
The assay method established by Share (16) and Sawer (17) was modified. Male Wistar rats weighing about 200 g were fasted for about 16 hr, after which an oral adminis tration of 50 ml/kg of 12 "" ethanol was given. Polyethylene tube was inserted into the jugular vein for the injection of test solutions. The urinary bladder was exposed through a low, 1111(11111C, abdominal incision. The urethra was ligated, and the bladder catheterized with polyethylene tube provided with an electrode. The electrode consisted of two short stainless steel tubes separated by a short polyethylene tube. The abdomen was then sutured. Next 30 ml/kg of 2.5 ethanol was given via a stomach tube. Urine conductivity was in duced by the electrode of the cannula in the bladder, and the changes were amplified by a conductivity meter and recorded. During the assay 2.5% ethanol was given via sto mach tube, with the intention to compensate the urinary loss of water in the animals: this procedure also served to maintain the anesthesia throughout the experiment. L icrus and vagina iii inn Healthy white rabbits weighing about 3.6 kg (on the 30-31 day of pregnancy) and Wistar rats weighing about 350 g (on the 20-22 day of pregnancy) were used. Laparo tomy was performed under urethane (1.5 g/kg, s.c.) anesthesia. A rubber balloon was inserted into one of the uterine horns after careful removal of the one foetus. A poly ethylene cannula was connected to the balloon. After closing the incision, the other end of the cannula was led to an electric manometer. With an electric manometer and a car rier amplifier, changes of intra-uterine pressure were measured and recorded. Changes of intra-vaginal pressure were also recorded on some occasions. The left femoral vein was cannulated with polyethylene tube for intravenous injection. Biochemical properties (I) Preparation of enzyme solutions: Wistar rats weighing about 180 g in the stage of oestrus induced by diethylstilbestrol and Wistar rats weighing about 350 g on the 20 22 day of pregnancy were used. Rats were stunned by a blow on the head and exsan guinated, and three viscera were removed and weighed. A mixture of I g of the wet tissue and 0. 1 M phosphate buffer (9 ml for kidney or liver, 4 ml for uterus) was homogenated at 0°C and centrifuged at 700 ~ g for 10 min to remove cell debris. The supernatant was separated and used as the enzyme solution. Rat serum was obtained by the centrifuga tion of arterial blood at 700 g for 10 min and used as an enzyme solution without dilu tion. Serum and saliva were obtained from women in the last month of pregnancy and stored in a freezer. On the day of experiment, these were allowed to melt and used as enzyme solution without dilution.
(2) Preparation of substrate: Y-5350 or oxytocin was dissolved in (I: 400) acetic acid in a concentration of about 8 units per ml. These were diluted 50 times with 0.1 M phosphate buffer solution and used as the substrate.
(3) pH of phosphate buffer so/ration: The pl-i of solution was 6.5 in the study of the enzymatic action using viscera and saliva, and 7.4 in the study of the enzymatic action using the serum.
(4) Determination of enzymatic actii,itie.ss: To 0.6 ml of the enzyme solution, prein cubated in 2.6 nil of the 0. 1 M phosphate buffer solution, was added 0.8 ml of the substrate solution and incubation at 37'C was carried out. The residual oxytocic activities were determined by analysing the aliquots of reaction mixture. These were tested on the iso lated rat uterus according to the method described above.
RESULTS
Oxytocin and vasopressin-like activities
The biological activities of Y-5350, Y-4266 and oxytocin are shown in Table 1 . Fig. 1 and Fig. 2 , respectively.
Affinity constant and intrinsic activity
The cumulative dose-response curves of Y-5350 and oxytocin are shown in Table 2 .
Oxytocic activities in rats and rabbits in vivo
Oxytocic activities of Y-5350 in viva were compared with those of oxytocin in preg nant animals. Typical data are shown in Fig. 5 and Fig. 6 . In both figures, the dose injected in all cases was equal to that obtained in the oxytocic assay in vitro. In the preg nant rats and rabbits, uterine contracting responses were weak with a single dose of Y-5350.
In this study, intravaginal pressure changes induced by a single injection of Y-5350 and oxytocin were also recorded. Y-5350 and oxytocin showed no obvious effect on vaginal movement, when injected at a dose range from 5 to 50 mu/kg (Fig. 6 ).
Enzymatic inactivation in vitro
The results of the enzymatic inactivation of Y-5350 and oxytocin in vitro are shown in Fig. 7 and Fig. 8 . Oxytocin destroying activities were observed in the serum of pregnant women. However, oxytocin was stable in serum of rats, and in saliva of pregnant women.
In both pregnant and non-pregnant rats, extracts of uterus, kidney and liver showed oxy tocin destroying activities.
On the contrary, the activity of Y-5350 was maintained in the serum of pregnant women, and also in the above three tissue extracts of rats tinder the same condition. Pharmacological studies involving the response in vitro of the rat uterus to cumula tive increases in the dosage of Y-5350 and oxytocin were carried out. Yamanaka et al. (8) reported that intrinsic activity of Y-4266 was only 68°o that of oxytocin.
In the pre sent study, intrinsic activity of Y-5350 was revealed to be the same as that of oxytocin.
However, the cumulative dose-response curve of Y-5350 was steeper than that of oxytocin.
In the above cumulative experiment, the influence of 0.5 mM magnesium ion was also investigated on the oxytocic activities of Y-5350. Many investigators using various or gans reported the enhancement of biological activities of oxytocin by magnesium ion (12, (19) (20) (21) (22) . The affinity of Y-5350 to isolated rat uterus was much enhanced by the addition of 0.5 mM magnesium ion to the bathing fluid, a phenomenon similar to that of oxytocin.
Furthermore, with respect to the role of magnesium ion on the oxytocic activity of neurohypophysial hormones in vitro and hi rive, C'han and Kelley (23) reported the com plete agreement between in viro and irr vitro activities, which was assayed in the presence of 2 mM magnesium ion being equal to the normal serum level. In Y-5350, however, such agreement between in viva and in vitro was not observed. Consequently, further studies were done to elucidate the difference between Y-5350 and oxytocin in terms of the bio logical activities in rivo. It has been reported that the oxytocin destroying enzyme, oxy tocinase, is present in pregnant women and in pregnant rhesus monkey (24) . However, no oxytocin destroying activity was detected in (he plasma of other nonpregnant or preg nant animals of the mammalian. Oxytocin was destroyed by the extracts of uterus (25) , kidney (26) and liver (25) . In contrast with oxytocin, Y-5350 was not destroyed by the serum of pregnant women and by the extracts of rat's uterus, kidney and liver under the same conditions. In a recent study (27) , the half-life time of Y-5350 in the blood was about 2-3 min in rabbits. This value was nearly the same as that of oxytocin reported by C'hattdhure and Walker (28) .
Finally, the lack of agreement between hi viva and in vitro oxytocic activity of Y-5350 remains to be investigated. It is a most interesting feature that Y-5350 has specific uteroconstrictive activity (oxytocin-like) with little effect on blood pressure (vasopres
